Back
Compare AU
Compare IEAT vs. CURE
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are IEAT and CURE. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
--- | CURE | |
|---|---|---|
Popularity | N/A | Low |
Pearlers invested | 0 | 69 |
Median incremental investment | - | $672.94 |
Median investment frequency | N/A | Monthly |
Median total investment | $0 | $1,925.41 |
Average age group | N/A | > 35 |
Key Summary
--- | CURE | |
|---|---|---|
Strategy | N/A | CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index. |
Top 3 holdings | Apellis Pharmaceuticals Inc (1.72 %) Revolution Medicines Inc Ordinary Shares (1.57 %) Summit Therapeutics Inc Ordinary Shares (1.52 %) | |
Top 3 industries | Health Care (100.00 %) Other (10.24 %) | |
Top 3 countries | United States (96.62 %) United Kingdom of Great Britain and Northern Ireland (1.35 %) Switzerland (1.13 %) | |
Management fee | N/A | 0.45 % |
Key Summary
--- | CURE | |
|---|---|---|
Issuer | N/A | Global X |
Tracking index | N/A | S&P Biotechnology Select Industry |
Asset class | Stock | ETF |
Management fee | N/A | 0.45 % |
Price | $-- | $60.64 |
Size | N/A | $41.905 million |
10Y return | N/A | N/A |
Annual dividend/ distribution yield (5Y) | - % | 5.08 % |
Market | ASX | ASX |
First listed date | N/A | 12/11/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
--- | CURE | |
|---|---|---|
Popularity | N/A | Low |
Pearlers invested | 0 | 69 |
Median incremental investment | - | $672.94 |
Median investment frequency | N/A | Monthly |
Median total investment | $0 | $1,925.41 |
Average age group | N/A | > 35 |
Pros and Cons
--- | CURE | |
|---|---|---|
Pros |
|
|
Cons |
|
|
--- | CURE |
|---|---|
Exposure to 1 market and 1 sector only | Exposure to more markets and sectors |
Higher price growth | Lower price growth |
Lower dividend/distribution yield | Higher dividend/distribution yield |